Quarter Period Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7717381

Concept 2018-04-01 to
2018-09-30
Quarter period statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
23,760,000 JPY
Operating profit (loss)
-237,220,000 JPY
Non-operating income
Interest income
15,000 JPY
Non-operating income
378,000 JPY
Non-operating expenses
Interest expenses
171,000 JPY
Non-operating expenses
40,824,000 JPY
Ordinary profit (loss)
-277,665,000 JPY
Profit (loss) before income taxes
-277,665,000 JPY
Income taxes - current
952,000 JPY
Income taxes
952,000 JPY
Profit (loss)
-278,618,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.